Yahoo
Toronto - Delayed Quote CAD

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

9.71 +0.48 (+5.20%)
At close: November 6 at 4:00:00 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Cash Flow from Operating Activities, Indirect
-37,473.79 -28,552.22 -29,994.49 -20,748.62 -14,395.20
Cash Flow from Investing Activities
-80,478.29 -588.95 -75.16 -73.38 9,834.37
Cash Flow from Financing Activities
151,448.19 76,058.54 45,784.21 21,078.97 10,801.08
Cash and Cash Equivalents, End of Period
52,426.17 80,563.48 33,101.29 19,341.76 18,263.39
Cash Flow, Supplemental
Free Cash Flow to Firm
-43,877.75 -28,427.47 -22,820.99 -25,310.29 -15,162.47
Capital Expenditure, Calculated
753.72 588.95 104.23 73.38 235.55
Issuance of Capital Stock
123,255.77 73,891.11 54,558.61 15,886.54 10,636.58
Repurchase of Capital Stock
0 0 0 0 0
12/31/2022 - 3/9/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: